BIORESTORATIVE THERAPIES, INC. Retained Earnings
BIORESTORATIVE THERAPIES, INC. (BRTX) had Retained Earnings of -$172.08 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-14
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$172.08M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$169.92M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$166.71M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$163.67M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-03-31 | -$172.08M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$169.92M 10-Q · filed 2026-05-14 | |
| 2025-09-30 | -$166.71M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$163.67M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$161.02M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$155.68M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$154.04M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$152.95M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$148.92M 10-Q · filed 2024-06-11 | |
| 2023-12-31 | -$146.70M 10-K · filed 2025-03-28 | -$167.06M 10-K · filed 2024-04-01 |
| 2023-09-30 | -$144.40M 10-K/A · filed 2024-06-11 | -$164.23M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$149.16M 10-K/A · filed 2024-06-11 | -$161.31M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$143.45M 10-K/A · filed 2024-06-11 | -$158.33M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$136.28M 10-K/A · filed 2024-06-11 | -$152.64M 10-K · filed 2023-03-27 |
| 2022-09-30 | -$133.61M 10-K/A · filed 2024-06-11 | -$148.29M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$128.17M 10-K/A · filed 2024-06-11 | -$143.64M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$131.27M 10-K/A · filed 2024-06-11 | -$138.96M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$134.15M 10-K · filed 2023-03-27 | |
| 2021-09-30 | -$113.74M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$109.56M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$105.50M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$89.84M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$84.08M 10-Q · filed 2021-04-12 | |
| 2020-06-30 | -$83.25M 10-Q · filed 2021-04-12 | |
| 2020-03-31 | -$86.12M 10-Q · filed 2021-03-29 | |
| 2019-12-31 | -$78.57M 10-K · filed 2021-04-30 | |
| 2019-09-30 | -$77.02M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$71.96M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$67.81M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$63.92M 10-K · filed 2021-03-18 | |
| 2018-09-30 | -$60.35M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$57.43M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$53.91M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$51.40M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$49.54M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$47.49M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$44.75M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$41.96M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$39.90M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$38.07M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$35.81M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | -$33.32M 10-K · filed 2017-03-22 | |
| 2015-09-30 | -$30.20M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | -$28.58M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$27.16M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$25.40M 10-K · filed 2016-03-30 | |
| 2013-12-31 | -$19.81M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |